349 related articles for article (PubMed ID: 30575145)
1. Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI study.
Sabouri S; Chang SD; Goldenberg SL; Savdie R; Jones EC; Black PC; Fazli L; Kozlowski P
NMR Biomed; 2019 Feb; 32(2):e4048. PubMed ID: 30575145
[TBL] [Abstract][Full Text] [Related]
2. Luminal Water Imaging: Comparison With Diffusion-Weighted Imaging (DWI) and PI-RADS for Characterization of Prostate Cancer Aggressiveness.
Hectors SJ; Said D; Gnerre J; Tewari A; Taouli B
J Magn Reson Imaging; 2020 Jul; 52(1):271-279. PubMed ID: 31961049
[TBL] [Abstract][Full Text] [Related]
3. Luminal Water Imaging: A New MR Imaging T2 Mapping Technique for Prostate Cancer Diagnosis.
Sabouri S; Chang SD; Savdie R; Zhang J; Jones EC; Goldenberg SL; Black PC; Kozlowski P
Radiology; 2017 Aug; 284(2):451-459. PubMed ID: 28394754
[TBL] [Abstract][Full Text] [Related]
4. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
[TBL] [Abstract][Full Text] [Related]
5. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.
Gondo T; Hricak H; Sala E; Zheng J; Moskowitz CS; Bernstein M; Eastham JA; Vargas HA
Eur Radiol; 2014 Dec; 24(12):3161-70. PubMed ID: 25100337
[TBL] [Abstract][Full Text] [Related]
7. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the need for DCE MRI in the detection of dominant lesions in the whole gland: Correlation between histology and MRI of prostate cancer.
Kozlowski P; Chang SD; Jones EC; Goldenberg SL
NMR Biomed; 2018 Mar; 31(3):. PubMed ID: 29266527
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging.
Fusco R; Sansone M; Petrillo M; Setola SV; Granata V; Botti G; Perdonà S; Borzillo V; Muto P; Petrillo A
Magn Reson Imaging; 2016 Sep; 34(7):839-45. PubMed ID: 27071309
[TBL] [Abstract][Full Text] [Related]
12. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
Zhang Z; Xu H; Xue Y; Li J; Ye Q
J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
[TBL] [Abstract][Full Text] [Related]
13. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.
Panebianco V; Barchetti F; Sciarra A; Musio D; Forte V; Gentile V; Tombolini V; Catalano C
Eur Radiol; 2013 Jun; 23(6):1745-52. PubMed ID: 23377546
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?
Donati OF; Jung SI; Vargas HA; Gultekin DH; Zheng J; Moskowitz CS; Hricak H; Zelefsky MJ; Akin O
Radiology; 2013 Aug; 268(2):440-50. PubMed ID: 23481164
[TBL] [Abstract][Full Text] [Related]
16. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.
Vos EK; Litjens GJ; Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ; Scheenen TW
Eur Urol; 2013 Sep; 64(3):448-55. PubMed ID: 23751135
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
18. MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histology.
Sabouri S; Fazli L; Chang SD; Savdie R; Jones EC; Goldenberg SL; Black PC; Kozlowski P
J Magn Reson Imaging; 2017 Sep; 46(3):861-869. PubMed ID: 28130866
[TBL] [Abstract][Full Text] [Related]
19. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
20. MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.
Schimmöller L; Quentin M; Arsov C; Hiester A; Buchbender C; Rabenalt R; Albers P; Antoch G; Blondin D
Eur Radiol; 2014 Oct; 24(10):2582-9. PubMed ID: 24972954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
